CHAI Lies: People Die

“Who cares? It’s just blacks dying.”

As I discussed in a prior post on the Clinton Health Access Initiative (‘CHAI’), there are a number of questions regarding basic corporate law formalities related to CHAI that betray, at a minimum, an indifference to applicable laws, rule and regulations. Simply put, there is a lot of smoke that suggests there must be a fire. A US Congressional Report focused on CHAI available here (the “Report”) provides evidence that not only is there a fire it is one that is hellish in nature. Criticism of the Clintons has long since reached a saturation point where even implying there is something demonic about them might not seem shocking. Nevertheless, with an election looming it is imperative that as many people as possible come to terms with such an implication as soon as possible. The Report suggests the wrongdoing goes all the way back to when Bill Clinton was in office. Because of how it relates to years of US government policy may well not merely taint but shame the US as a country.

A Voting Decision Is In Effect A Judgment Of Character Not To Be Confused With Trial Procedure

The ‘news’ media in the US tends to frame practically every political issue as if it needs to be resolved by the standards of a criminal trial — beyond a reasonable doubt. Not only is that an absurd standard to apply to what is in effect a judgment of character that goes into deciding to vote for someone or not, it is in general not how humans think logically. It is in fact entirely logical to make educated guesses on a daily basis: your survival at times depends upon such guesses. In what follows I am going to touch upon issues that should go into a guess about what more is to come about CHAI, the Clinton Foundation and the Clintons.

Dirty Medicine: A Fortune Magazine Expose On A Drug Company Located In India

A few years ago Fortune, a the well respected business magazine, published an expose on a drug company located in India known by the odd sounding name of Ranbaxy. To keep a long story short, the title of the article effectively says it all: Ranbaxy was making money by selling drugs that did not live up to the name it put on them. Among those drugs were the ones that CHAI marketed for the treatment of HIV/AIDS. An American physician interviewed by Fortune quoted an executive of Ranbaxy as saying that the fact that such drugs were not as effective as those available from other companies: “Who cares? It’s just blacks dying.”

As provocative a statement as that is it actually distracts attention from a sadly obvious fact. What has made HIV/AIDS so horrific is how difficult it is to treat effectively absent a combination of the very best in high tech drugs administered and monitored in the very best of conditions. To think you can cut corners in treating it is to indulge in a fantasy that there is no evidence has ever become a reality. CHAI in essence has been selling that fantasy. The reality, it is sadly reasonable to infer, is that directly as a result of what CHAI has done or facilitated is that people have lived far more painful lives than they might otherwise have and then they have died.

A Suspicious Executive Order

The Report calls attention to an Executive Order (the ‘EO’, itself a ‘form’ of Presidential action that has long been viewed suspiciously for its imperialistic character) that essentially tied the US government’s hands behind its back as it relates to but one area of the world and one issue: the Sub Saharan Africa and HIV/AIDS medication. The takeaway from a ‘charitable’ reading of the EO and the context the Report provides for it is that what is good for US citizens is not good enough for Sub Saharan Africa. That should be disturbing enough, but it gets worse.

The CHAI Lie Ab Initio

If you buy into the Clinton Foundation narrative, Bill Clinton’s eleemosynary instinct was triggered by concern for those suffering from HIV/AIDS some time in 2002. That is clearly a lie because the EO suggests that he was bribed into loosening restrictions that were preventing non-US drug companies, eager to evade US patent laws, from competing for HIV/AIDS business. And do not be fooled: HIV/AIDS is from the perspective of any drug company nothing more than a business opportunity: at issue is only whether they should be allowed into that ‘marketplace.’

A Money Machine Is Not Frictionless

The basic theme of all Clinton Foundation narratives is that it functions essentially as a ‘pass through’ entity for donations to “initiatives” it identifies as being worthy of such donations. Yet, CHAI has purported and continues to purport to do more than that, for it has boasted of lowering drug costs by negotiating country specific deals with particular drug companies. Cut through all the crap and what this means is that CHAI has had lots of money passing through and around it. Even the most transparent of money ‘brokers’ — for example a public money market fund subject to SEC regulation — has management fees and also pays others all sorts of commissions and other fees. Put simply (something difficult to do when the Clintons are involved): a money machine is not frictionless and at each and every ‘friction point’ there is money to be made and lost. That is true whether or not the machine in question is officially categorized as ‘non-profit’ or not.

Skimming Off US Government Funds

The Report points to a US government funded initiative related to HIV/AIDS treatment that began in 2003 and accelerated in 2004. Though the authors of the Report do not seem to have had the benefit of the corporate formality issues identified in my first ‘CHAI Lie’ post, that funding would seem to explain why CHAI was first organized as a legal entity in 2004. The underlying rationale probably related to qualifying to become one of the ‘friction points’ in how such US government funds went from point A to point B.